Samuel Levy

Title: Samuel Levy: Innovator in Nucleic Acid Analysis

Introduction

Samuel Levy is a notable inventor based in San Diego, CA (US). He has made significant contributions to the field of nucleic acid analysis, particularly in the context of assigning tissue of origin from cell-free samples. His innovative approach has the potential to enhance diagnostic methods in medical science.

Latest Patents

Samuel Levy holds a patent for a method titled "Hydroxymethylation analysis of cell-free nucleic acid samples for assigning tissue of origin, and related methods of use." This patent describes a method for probabilistically assigning a tissue of origin to nucleic acids in samples, such as DNA obtained from human subjects. The process involves generating a hydroxymethylation profile for the sample DNA and comparing it against a reference data set. This comparison allows for the probabilistic assignment of the tissue of origin based on specific reference loci and associated tissue-specific genes.

Career Highlights

Samuel Levy is currently associated with Clearnote Health, Inc., where he applies his expertise in nucleic acid analysis. His work focuses on developing innovative methods that can improve the accuracy of tissue identification from cell-free samples. With a patent portfolio that includes 1 patent, he continues to push the boundaries of research in this critical area.

Collaborations

Samuel has collaborated with Chin-Jen Ku, contributing to advancements in their shared field of research. Their partnership exemplifies the importance of teamwork in driving innovation and achieving breakthroughs in scientific research.

Conclusion

Samuel Levy's contributions to nucleic acid analysis represent a significant advancement in the field. His patented methods have the potential to improve diagnostic accuracy and enhance our understanding of tissue origins. Through his work at Clearnote Health, Inc., he continues to make strides in medical research and innovation.